Financing Drugs in South-East Asia - Report of the First Meeting of the WHO/SEARO Working Group on Drug Financing, Korat, Thailand, 26-28 November 1996 - Health Economics and Drugs Series No. 004
(1997; 72 pages) Ver el documento en el formato PDF
Índice de contenido
Abrir esta carpeta y ver su contenidoExecutive summary
Abrir esta carpeta y ver su contenido1. Introduction
Abrir esta carpeta y ver su contenido2. Country presentations on drug financing
Abrir esta carpeta y ver su contenido3. Korat provincial field visit
Abrir esta carpeta y ver su contenido4. Drug financing issues
Abrir esta carpeta y ver su contenido5. Country priorities for drug financing
Cerrar esta carpeta6. Priorities for work group action
Ver el documento6.1 Group A
Ver el documento6.2 Group B
Abrir esta carpeta y ver su contenido7. Conclusions and recommendations
Ver el documentoAnnex A. Agenda
Ver el documentoAnnex B. List of participants
Ver el documentoAnnex C. List of documents
Ver el documentoAnnex D. Message from Regional Director, WHO South-East Asia Region
Abrir esta carpeta y ver su contenidoAnnex E. Evaluation of the meeting. Priorities for the Working Group
 

6. Priorities for work group action

After each country had discussed its priorities, participants were paired into two groups; Group A (Thai-Indonesia) and Group B (Nepal-Myanmar) and they discussed tasks for work group action on priorities listed earlier. Abbreviations in parentheses indicate which countries chose particular issues as a priority.

TASKS

For each of the priority issues indicate:

1. What might be done at the country-level to address the issue?

2. What information-sharing or other actions involving the four countries and WHO would help to address the issue?

3. What should be done at the next Working Group meeting in terms of field visits, presentations, discussions, or other actions?

Summary of the two work groups:

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013